Inhibition of HSP90 with AUY922 induces synergy in HER2-amplified trastuzumab-resistant breast and gastric cancer.
about
Mechanisms Behind the Resistance to Trastuzumab in HER2-Amplified Breast Cancer and Strategies to Overcome ItChanging strategies for target therapy in gastric cancerTargeting the PI3K/Akt signaling pathway in gastric carcinoma: A reality for personalized medicine?Hsp90 inhibitor SY-016 induces G2/M arrest and apoptosis in paclitaxel-resistant human ovarian cancer cellsAssociation between HSP90 and Her2 in gastric and gastroesophageal carcinomas.Recent advances in the HER2 targeted therapy of gastric cancerGeldanamycin induces apoptosis in human gastric carcinomas by affecting multiple oncogenic kinases that have synergic effects with TNF-related apoptosis-inducing ligand.Targeting heat-shock protein 90 with ganetespib for molecularly targeted therapy of gastric cancerHelicobacter pylori: gastric cancer and extragastric malignancies - clinical aspects.Trastuzumab: a review of its use in HER2-positive advanced gastric cancer.Targeting HER 2 and angiogenesis in gastric cancer.Targeting cancer cell mitochondria as a therapeutic approach: recent updates.Regulation of Apoptosis by HER2 in Breast Cancer.An inducible heat shock protein 70 small molecule inhibitor demonstrates anti-dengue virus activity, validating Hsp70 as a host antiviral target.Ganetespib induces G2/M cell cycle arrest and apoptosis in gastric cancer cells through targeting of receptor tyrosine kinase signaling.Therapeutic potency of heat-shock protein-90 pharmacological inhibitors in the treatment of gastrointestinal cancer, current status and perspectives.HSP90 inhibitor AUY922 abrogates up-regulation of RTKs by mTOR inhibitor AZD8055 and potentiates its antiproliferative activity in human breast cancer.HER2 inhibition in gastro-oesophageal cancer: A review drawing on lessons learned from breast cancerDevelopment of a novel Hsp90 inhibitor NCT-50 as a potential anticancer agent for the treatment of non-small cell lung cancer
P2860
Q26752780-9CDA8201-C24E-4DA8-BA71-3498070ACE9BQ26774513-58A47559-E4D5-4344-A090-ABFD76098C60Q26775940-D1D6F077-5782-4F50-9F4C-4BFE5B00D2D2Q33598733-25DB0996-A16F-446B-B16F-3F043F648EB8Q34852929-10F56B47-7909-4329-AC7F-BFCF0F2C7C2FQ34967104-953E3593-1E5E-4B38-9521-86C0E5B81644Q36334890-6BA2990F-574C-487B-AAC7-EA83D0BAF2F5Q36347106-7E5E3618-5039-4884-BA67-5D2A860FFC07Q38134872-BFF00CA8-7EE3-4140-8A36-06215F508AF0Q38140697-7592E63F-E9AE-4203-8EDD-7F2798B31FEFQ38633308-7E5ED4A2-CD94-4697-98AF-6B70012B6108Q38668524-A41F661D-A73C-4A7A-8888-198084127B05Q39843650-6C0B879A-3396-4D50-816B-91D846FECCBBQ40110604-A6A67E8E-629C-49C2-9EF9-B3E043E4FCB4Q41470003-34067BCE-E20D-4243-8A97-47F76747B4A0Q47694405-6A040D92-BD45-4985-A05B-5FFC515DF8FEQ53059131-119702B9-2B9C-480B-AEE1-53BE6CC65868Q57109545-F5A20863-2038-4D18-85C3-4C6F71090B27Q58734093-0829564C-8E96-4B45-84DC-ECAA767F1ECD
P2860
Inhibition of HSP90 with AUY922 induces synergy in HER2-amplified trastuzumab-resistant breast and gastric cancer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Inhibition of HSP90 with AUY92 ...... ant breast and gastric cancer.
@en
Inhibition of HSP90 with AUY92 ...... ant breast and gastric cancer.
@nl
type
label
Inhibition of HSP90 with AUY92 ...... ant breast and gastric cancer.
@en
Inhibition of HSP90 with AUY92 ...... ant breast and gastric cancer.
@nl
prefLabel
Inhibition of HSP90 with AUY92 ...... ant breast and gastric cancer.
@en
Inhibition of HSP90 with AUY92 ...... ant breast and gastric cancer.
@nl
P2093
P1476
Inhibition of HSP90 with AUY92 ...... ant breast and gastric cancer.
@en
P2093
Adrian Anghel
Amrita J Desai
Amy M Rogers
Cornelia Quadt
Dennis J Slamon
Dylan Conklin
Mikhail Akimov
Neil A O'Brien
Ondrej Kalous
Raul Ayala
P304
P356
10.1158/1535-7163.MCT-12-0507
P577
2013-02-08T00:00:00Z